Cargando…
PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus. PPARα and PPARγ anti-inflammatory, antiproliferative a...
Autores principales: | Tesse, Angela, Andriantsitohaina, Ramaroson, Ragot, Thierry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659552/ https://www.ncbi.nlm.nih.gov/pubmed/19325917 http://dx.doi.org/10.1155/2009/745821 |
Ejemplares similares
-
Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the Endothelium
por: Chalopin, Matthieu, et al.
Publicado: (2010) -
Circulating Microparticles from Crohn’s Disease Patients Cause Endothelial and Vascular Dysfunctions
por: Leonetti, Daniela, et al.
Publicado: (2013) -
Microparticles as biological vectors of activated protein C treatment in sepsis
por: Andriantsitohaina, Ramaroson
Publicado: (2011) -
Red Wine Polyphenol Compounds Favor Neovascularisation through Estrogen Receptor α-Independent Mechanism in Mice
por: Chalopin, Matthieu, et al.
Publicado: (2014) -
PPARδ, a Potential Therapeutic Target for Heart Disease
por: Yang, Qinglin, et al.
Publicado: (2018)